vs

Side-by-side financial comparison of ASSEMBLY BIOSCIENCES, INC. (ASMB) and Pathfinder Bancorp, Inc. (PBHC). Click either name above to swap in a different company.

Pathfinder Bancorp, Inc. is the larger business by last-quarter revenue ($11.8M vs $10.8M, roughly 1.1× ASSEMBLY BIOSCIENCES, INC.). Pathfinder Bancorp, Inc. runs the higher net margin — -52.9% vs -85.2%, a 32.3% gap on every dollar of revenue. On growth, ASSEMBLY BIOSCIENCES, INC. posted the faster year-over-year revenue change (57.6% vs -22.6%). Pathfinder Bancorp, Inc. produced more free cash flow last quarter ($10.4M vs $-15.2M).

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

Pathfinder Bancorp, Inc. is a regional bank holding company headquartered in New York, U.S. It operates Pathfinder Bank serving the central New York market, offering retail and commercial banking services including deposit accounts, mortgages, business loans and wealth management for individual consumers and small to medium-sized enterprises.

ASMB vs PBHC — Head-to-Head

Bigger by revenue
PBHC
PBHC
1.1× larger
PBHC
$11.8M
$10.8M
ASMB
Growing faster (revenue YoY)
ASMB
ASMB
+80.3% gap
ASMB
57.6%
-22.6%
PBHC
Higher net margin
PBHC
PBHC
32.3% more per $
PBHC
-52.9%
-85.2%
ASMB
More free cash flow
PBHC
PBHC
$25.6M more FCF
PBHC
$10.4M
$-15.2M
ASMB

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ASMB
ASMB
PBHC
PBHC
Revenue
$10.8M
$11.8M
Net Profit
$-9.2M
$-5.6M
Gross Margin
Operating Margin
-100.9%
-81.1%
Net Margin
-85.2%
-52.9%
Revenue YoY
57.6%
-22.6%
Net Profit YoY
4.3%
-242.4%
EPS (diluted)
$-0.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASMB
ASMB
PBHC
PBHC
Q4 25
$11.8M
Q3 25
$10.8M
$13.1M
Q2 25
$9.6M
$9.3M
Q1 25
$9.4M
$12.6M
Q4 24
$7.4M
$15.3M
Q3 24
$6.8M
$13.4M
Q2 24
$8.5M
$10.7M
Q1 24
$5.8M
$11.1M
Net Profit
ASMB
ASMB
PBHC
PBHC
Q4 25
$-5.6M
Q3 25
$-9.2M
$626.0K
Q2 25
$-10.2M
$31.0K
Q1 25
$-8.8M
$3.0M
Q4 24
$3.9M
Q3 24
$-9.6M
$-4.6M
Q2 24
$-11.2M
$2.0M
Q1 24
$-9.1M
$2.1M
Operating Margin
ASMB
ASMB
PBHC
PBHC
Q4 25
-81.1%
Q3 25
-100.9%
5.1%
Q2 25
-115.2%
0.4%
Q1 25
-105.5%
29.5%
Q4 24
55.4%
Q3 24
-160.1%
-43.1%
Q2 24
-143.0%
23.3%
Q1 24
-185.5%
24.3%
Net Margin
ASMB
ASMB
PBHC
PBHC
Q4 25
-52.9%
Q3 25
-85.2%
4.8%
Q2 25
-105.9%
0.3%
Q1 25
-93.6%
23.6%
Q4 24
37.7%
Q3 24
-140.4%
-34.6%
Q2 24
-130.7%
18.7%
Q1 24
-156.9%
19.0%
EPS (diluted)
ASMB
ASMB
PBHC
PBHC
Q4 25
Q3 25
$-0.72
$0.47
Q2 25
$-1.33
$0.47
Q1 25
$-1.17
Q4 24
Q3 24
$-1.51
$0.41
Q2 24
$-1.98
$0.41
Q1 24
$-1.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASMB
ASMB
PBHC
PBHC
Cash + ST InvestmentsLiquidity on hand
$22.5M
Total DebtLower is stronger
$14.1M
Stockholders' EquityBook value
$182.7M
$122.5M
Total Assets
$240.0M
$1.4B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASMB
ASMB
PBHC
PBHC
Q4 25
Q3 25
$22.5M
Q2 25
$24.0M
Q1 25
$23.4M
Q4 24
$38.3M
Q3 24
$28.5M
Q2 24
$19.2M
Q1 24
$18.7M
Total Debt
ASMB
ASMB
PBHC
PBHC
Q4 25
$14.1M
Q3 25
$18.7M
Q2 25
$21.0M
Q1 25
$17.6M
Q4 24
$27.1M
Q3 24
$39.8M
Q2 24
$45.9M
Q1 24
$45.9M
Stockholders' Equity
ASMB
ASMB
PBHC
PBHC
Q4 25
$122.5M
Q3 25
$182.7M
$126.3M
Q2 25
$18.1M
$124.4M
Q1 25
$27.1M
$124.9M
Q4 24
$33.4M
$121.5M
Q3 24
$26.0M
$120.2M
Q2 24
$34.7M
$123.3M
Q1 24
$32.6M
$121.8M
Total Assets
ASMB
ASMB
PBHC
PBHC
Q4 25
$1.4B
Q3 25
$240.0M
$1.5B
Q2 25
$80.8M
$1.5B
Q1 25
$99.0M
$1.5B
Q4 24
$119.2M
$1.5B
Q3 24
$100.3M
$1.5B
Q2 24
$115.3M
$1.4B
Q1 24
$119.9M
$1.5B
Debt / Equity
ASMB
ASMB
PBHC
PBHC
Q4 25
0.11×
Q3 25
0.15×
Q2 25
0.17×
Q1 25
0.14×
Q4 24
0.22×
Q3 24
0.33×
Q2 24
0.37×
Q1 24
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASMB
ASMB
PBHC
PBHC
Operating Cash FlowLast quarter
$-15.1M
$11.7M
Free Cash FlowOCF − Capex
$-15.2M
$10.4M
FCF MarginFCF / Revenue
-140.7%
88.1%
Capex IntensityCapex / Revenue
0.4%
10.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$18.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASMB
ASMB
PBHC
PBHC
Q4 25
$11.7M
Q3 25
$-15.1M
$7.0M
Q2 25
$-16.8M
$-3.7M
Q1 25
$-23.4M
$5.7M
Q4 24
$-51.1M
$11.2M
Q3 24
$-15.2M
$11.8M
Q2 24
$-17.1M
$1.5M
Q1 24
$-18.4M
$504.0K
Free Cash Flow
ASMB
ASMB
PBHC
PBHC
Q4 25
$10.4M
Q3 25
$-15.2M
$6.9M
Q2 25
$-4.0M
Q1 25
$5.1M
Q4 24
$-51.1M
$9.1M
Q3 24
$11.3M
Q2 24
$-17.1M
$637.0K
Q1 24
$-18.4M
$274.0K
FCF Margin
ASMB
ASMB
PBHC
PBHC
Q4 25
88.1%
Q3 25
-140.7%
52.8%
Q2 25
-42.6%
Q1 25
40.1%
Q4 24
-695.2%
59.9%
Q3 24
84.3%
Q2 24
-200.6%
6.0%
Q1 24
-317.7%
2.5%
Capex Intensity
ASMB
ASMB
PBHC
PBHC
Q4 25
10.7%
Q3 25
0.4%
1.0%
Q2 25
0.0%
2.4%
Q1 25
0.0%
5.1%
Q4 24
0.4%
13.5%
Q3 24
0.0%
3.8%
Q2 24
0.2%
8.2%
Q1 24
0.2%
2.1%
Cash Conversion
ASMB
ASMB
PBHC
PBHC
Q4 25
Q3 25
11.26×
Q2 25
-120.55×
Q1 25
1.92×
Q4 24
2.87×
Q3 24
Q2 24
0.76×
Q1 24
0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASMB
ASMB

Segment breakdown not available.

PBHC
PBHC

Other$5.6M47%
Banking$3.7M31%
Deposit Account$1.5M13%
Financial Service Other$1.0M9%

Related Comparisons